The ROE as of June 2026 (TTM) for Bellerophon Therapeutics, Inc. (BLPH) is -164.21%

According to Bellerophon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -164.21%. This represents a change of 60.33% compared to the average of -102.42% of the last 4 quarters.

Bellerophon Therapeutics, Inc. (BLPH) Historical ROE (quarterly & annually)

How has BLPH ROE performed in the past?

The mean historical ROE of Bellerophon Therapeutics, Inc. over the last ten years is 73.57%. The current -164.21% ROE has changed -323.20% with respect to the historical average. Over the past ten years (40 quarters), BLPH's ROE was at its highest in in the December 2017 quarter at 931.34%. The ROE was at its lowest in in the March 2017 quarter at -2392.88%.

Bellerophon Therapeutics, Inc. (BLPH) ROE by Quarter and Year

Discovering the peaks and valleys of Bellerophon Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bellerophon Therapeutics, Inc. (BLPH) Average ROE

How has BLPH ROE performed in the past?

The current ROE of Bellerophon Therapeutics, Inc. (BLPH) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Bellerophon Therapeutics, Inc. (BLPH) ROE vs. Peers

How is BLPH’s ROE compared to its peers?

Bellerophon Therapeutics, Inc.’s ROE is less than Atlantic International Corp. (274.33%), greater than Akerna Corp. (-16.65%), greater than Histogen Inc. (-59.67%), less than Virios Therapeutics, Inc. (28.63%), less than Seelos Therapeutics, Inc. (171.72%), greater than TFF Pharmaceuticals, Inc. (-130.94%), greater than Immatics N.V. (-45.27%), greater than TC Biopharm (Holdings) Plc (-391.64%), greater than BioCardia, Inc. (-5456.14%),

Build a custom stock screener for Bellerophon Therapeutics, Inc. (BLPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellerophon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bellerophon Therapeutics, Inc. (BLPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bellerophon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.